Subramaniam Somu 的 Form 4 申報
Ventyx Biosciences, Inc.（VTYX），2023/4/25 申報
- 申報編號
- 0000899243-23-011699
- 申報時間
- 2023/4/25
- 交易日
- 2023/4/21-4/25
- 申報延遲
- 4 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 4 筆非衍生性交易。公開市場賣出合計 $385.4 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Subramaniam SomuCIK 0001508910 | 董事、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents the weighted average share price of an aggregate total of 8,642 shares sold in the price range of $37.50 to $37.555. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents the weighted average share price of an aggregate total of 25,139 shares sold in the price range of $37.50 to $38.50. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F11
Represents the weighted average share price of an aggregate total of 65,426 shares sold in the price range of $38.5004 to $39.17. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。